1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. DRUG DELIVERY SYSTEM MARKET BY DELIVERY SYSTEM
5.1. Introduction
5.2. Intra Uterine Implants
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.3. Pro-drug Implants
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Polymeric Drug Delivery
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Targeted Drug Delivery
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
6. DRUG DELIVERY SYSTEM MARKET BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Oral
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Injectable
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.4. Inhalation
6.4.1. Market Trends and Opportunities
6.4.2. Growth Prospects
6.5. Transdermal
6.5.1. Market Trends and Opportunities
6.5.2. Growth Prospects
6.6. Ocular
6.6.1. Market Trends and Opportunities
6.6.2. Growth Prospects
6.7. Nasal
6.7.1. Market Trends and Opportunities
6.7.2. Growth Prospects
6.8. Topical
6.8.1. Market Trends and Opportunities
6.8.2. Growth Prospects
7. DRUG DELIVERY SYSTEM MARKET BY APPLICATION
7.1. Introduction
7.2. Infectious Disease
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Oncology
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Ophthalmology
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
7.5. Urology
7.5.1. Market Trends and Opportunities
7.5.2. Growth Prospects
7.6. Diabetes
7.6.1. Market Trends and Opportunities
7.6.2. Growth Prospects
7.7. CNS
7.7.1. Market Trends and Opportunities
7.7.2. Growth Prospects
7.8. Others
7.8.1. Market Trends and Opportunities
7.8.2. Growth Prospects
8. DRUG DELIVERY SYSTEM MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Delivery System
8.2.2. By Route of Administration
8.2.3. By Application
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Trends and Opportunities
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Trends and Opportunities
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Trends and Opportunities
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Delivery System
8.3.2. By Route of Administration
8.3.3. By Application
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Trends and Opportunities
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Trends and Opportunities
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Trends and Opportunities
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Delivery System
8.4.2. By Route of Administration
8.4.3. By Application
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.1.1. Market Trends and Opportunities
8.4.4.1.2. Growth Prospects
8.4.4.2. Germany
8.4.4.2.1. Market Trends and Opportunities
8.4.4.2.2. Growth Prospects
8.4.4.3. France
8.4.4.3.1. Market Trends and Opportunities
8.4.4.3.2. Growth Prospects
8.4.4.4. Italy
8.4.4.4.1. Market Trends and Opportunities
8.4.4.4.2. Growth Prospects
8.4.4.5. Spain
8.4.4.5.1. Market Trends and Opportunities
8.4.4.5.2. Growth Prospects
8.4.4.6. Others
8.4.4.6.1. Market Trends and Opportunities
8.4.4.6.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Delivery System
8.5.2. By Route of Administration
8.5.3. By Application
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Trends and Opportunities
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Trends and Opportunities
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Trends and Opportunities
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Delivery System
8.6.2. By Route of Administration
8.6.3. By Application
8.6.4. By Country
8.6.4.1. Japan
8.6.4.1.1. Market Trends and Opportunities
8.6.4.1.2. Growth Prospects
8.6.4.2. China
8.6.4.2.1. Market Trends and Opportunities
8.6.4.2.2. Growth Prospects
8.6.4.3. India
8.6.4.3.1. Market Trends and Opportunities
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Trends and Opportunities
8.6.4.4.2. Growth Prospects
8.6.4.5. Taiwan
8.6.4.5.1. Market Trends and Opportunities
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Trends and Opportunities
8.6.4.6.2. Growth Prospects
8.6.4.7. Indonesia
8.6.4.7.1. Market Trends and Opportunities
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Trends and Opportunities
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Gerresheimer AG
10.2. BD (Becton, Dickinson and Company)
10.3. Kindeva Drug Delivery
10.4. Baxter
10.5. West Pharmaceutical Services Inc.
10.6. Ypsomed
10.7. Medtronic
10.8. Nemara
10.9. E3D Elcam Drug Delivery Devices